The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N4-((1R,2R)-2-(dimethylamino)cyclopentyl)-N2-(4-((S)-N-methylethylsulfonimidoyl)phenyl)-5-(trifluoromethyl)pyrimidine-2,4-diamine ID: ALA2448536
PubChem CID: 70692073
Max Phase: Preclinical
Molecular Formula: C21H29F3N6OS
Molecular Weight: 470.57
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC[S+]([O-])(=NC)c1ccc(Nc2ncc(C(F)(F)F)c(N[C@@H]3CCC[C@H]3N(C)C)n2)cc1
Standard InChI: InChI=1S/C21H29F3N6OS/c1-5-32(31,25-2)15-11-9-14(10-12-15)27-20-26-13-16(21(22,23)24)19(29-20)28-17-7-6-8-18(17)30(3)4/h9-13,17-18H,5-8H2,1-4H3,(H2-,25,26,27,28,29,31)/t17-,18-,32?/m1/s1
Standard InChI Key: MIZGEGJKPOLHOH-XZQBWAKSSA-N
Molfile:
RDKit 2D
32 34 0 0 0 0 0 0 0 0999 V2000
14.2037 -6.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4892 -5.9167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7748 -6.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7748 -7.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4892 -7.5667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2037 -7.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0603 -7.5667 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0603 -8.3917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7748 -8.8042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.7748 -9.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0603 -10.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3458 -9.6292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.3458 -8.8042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.9182 -5.9167 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
14.5057 -5.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6327 -5.5042 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.3307 -6.6312 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.0603 -10.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0603 -11.6917 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.2353 -10.8667 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.8853 -10.8667 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
13.4892 -10.0417 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4892 -10.8667 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.1567 -11.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9017 -12.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0767 -12.1363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8218 -11.3517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9413 -11.0967 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5544 -11.6488 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1128 -10.2898 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1557 -6.6312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6807 -5.2023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3 4 2 0
14 16 1 0
7 8 1 0
14 17 2 0
11 18 1 0
8 9 2 0
18 19 1 0
4 5 1 0
18 20 1 0
9 10 1 0
18 21 1 0
2 3 1 0
10 22 1 0
10 11 2 0
23 22 1 1
23 24 1 0
5 6 2 0
11 12 1 0
6 1 1 0
12 13 2 0
24 25 1 0
25 26 1 0
26 27 1 0
27 23 1 0
13 8 1 0
24 28 1 6
1 2 2 0
28 29 1 0
14 1 1 0
28 30 1 0
4 7 1 0
17 31 1 0
14 15 1 0
15 32 1 0
M CHG 2 14 1 16 -1
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 470.57Molecular Weight (Monoisotopic): 470.2076AlogP: 4.61#Rotatable Bonds: 7Polar Surface Area: 88.50Molecular Species: BASEHBA: 7HBD: 2#RO5 Violations: ┄HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.32CX Basic pKa: 9.31CX LogP: 3.69CX LogD: 1.78Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.57Np Likeness Score: -0.88
References 1. Walker DP, Zawistoski MP, McGlynn MA, Li JC, Kung DW, Bonnette PC, Baumann A, Buckbinder L, Houser JA, Boer J, Mistry A, Han S, Xing L, Guzman-Perez A.. (2009) Sulfoximine-substituted trifluoromethylpyrimidine analogs as inhibitors of proline-rich tyrosine kinase 2 (PYK2) show reduced hERG activity., 19 (12): [PMID:19428251 ] [10.1016/j.bmcl.2009.04.093 ]